[Form 4] Nuvectis Pharma, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Nuvectis Pharma, Inc. disclosed that Emerald Hill Ventures SARL SPF, which is beneficially owned by 10% owner Charles Mosseri Marlio, executed an open-market purchase of 50,000 shares of common stock at a weighted average price of $18.32 per share. After these transactions, Emerald Hill Ventures SARL SPF holds 3,186,576 shares indirectly, while Marlio also directly owns 109,321 shares of Nuvectis Pharma common stock.

Insights

Equity ownership analyst

Large shareholder adds 50,000 Nuvectis shares in open-market buy.

A beneficial owner of more than 10%, via Emerald Hill Ventures SARL SPF, reported buying 50,000 Nuvectis Pharma common shares at a weighted average price of $18.32. The purchases were standard open-market trades aggregated within a narrow price range.

Following the transaction, indirect holdings rose to 3,186,576 shares, with an additional 109,321 shares held directly. The filing does not reference any trading plan, and there are no derivative positions reported, so this reflects a straightforward net increase in equity exposure.

Insider Trade Summary

Net Buyer: 50,000 shares ($916,000)

Net Buy 2 txns

Insider Mosseri Marlio Charles

Role null

Bought 50,000 shs ($916K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	50,000	$18.32	$916K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,186,576 shares (Indirect, By Emerald Hill Ventures SARL SPF.); Common Stock — 109,321 shares (Direct, null)

Footnotes (1)

1. Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.29 to $18.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 01:42 PM Accepted by SEC EDGAR 07/01/2026 - 01:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mosseri Marlio Charles

(Last) (First) (Middle)

27 RIPPLEVALE GROVE

(Street)

LONDON N1 1HS

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvectis Pharma, Inc. [ NVCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		P		50,000	A	$18.32(1)	3,186,576(2)	I	By Emerald Hill Ventures SARL SPF.
Common Stock								109,321	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.29 to $18.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

2. Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.

	/s/ Charles Mosseri-Marlio	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)